News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
Digital Developing with start-up DNA As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company and the wider industry.
Partner Content Partner Content Review Microbiome Start-Up Success Stories & Business Models Your Invite - Microbiome Start-Up Focus Evening
Views & Analysis Exclusive: Frontiers Health – Day two coverage Frontiers Health is a two-day event focused on disruptive health; innovative technology, application of digital and new ideas which can, are and will transform the face
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
